Orient Europharma (Taiwan) Insiders
| 4120 Stock | TWD 42.60 1.20 2.74% |
Orient Europharma employs about 21 people. The company is managed by 21 executives with a total tenure of roughly 231 years, averaging almost 11.0 years of service per executive, having 1.0 employees per reported executive. Recap of Orient Europharma's management performance can provide insight into the venture performance.
| Zhenghong Cai Chairman Chairman of the Board, CEO |
| Jing Tsai Chairman Chairman of the Board |
Orient |
Orient Europharma Management Team Effectiveness
Orient Europharma's management efficiency ratios could be used to measure how well Orient Europharma manages its routine affairs as well as how well it operates its assets and liabilities.Orient Europharma Workforce Comparison
Orient Europharma Co is number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers-Specialty & Generic industry is presently estimated at about 23.0. Orient Europharma totals roughly 21.0 in number of employees claiming about 91% of equities under Drug Manufacturers-Specialty & Generic industry.
The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.01) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.01. Orient Europharma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Orient Europharma Price Series Summation is a cross summation of Orient Europharma price series and its benchmark/peer.
Orient Europharma Notable Stakeholders
An Orient Europharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Orient Europharma often face trade-offs trying to please all of them. Orient Europharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Orient Europharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Zhenghong Cai | Chairman of the Board, CEO | Profile | |
| Jing Tsai | Chairman of the Board | Profile | |
| Yuling Li | CFO | Profile | |
| Praveen Tyle | Independent Director | Profile | |
| Menglin Cai | Deputy General Manager-Management, Operation and Support Center, Director | Profile | |
| Wende Wang | Director | Profile | |
| Jizhou Liao | Director | Profile | |
| Junjie Wu | General Manager-Nutrition & Health Care, Director | Profile | |
| Huaming Lin | Independent Director | Profile | |
| Mon Tsai | General Manager, Director | Profile | |
| Shufen Lin | Director | Profile | |
| Anita Chen | Head of Corporate Public Affairs | Profile | |
| Jianming Tan | General Manager-Southeast Asia Area Nutrition & Health Business | Profile | |
| Liann Lai | Director Division | Profile | |
| Jiaxiu Lin | General Manager-Greater China Area Nutrition & Health Business | Profile | |
| Zhiping Zhang | General Manager-Western Medicine | Profile | |
| Jack Wu | Director | Profile | |
| Jinzeng Lu | General Manager-Western Medicine Brand Development & New Business Division | Profile | |
| Phoebe Lee | Chief Officer | Profile | |
| Yanjuan Chen | Head of Corporate Public Affairs | Profile | |
| Peter Tsai | CEO Chairman | Profile |
About Orient Europharma Management Performance
The success or failure of an entity such as Orient Europharma often depends on how effective the management is. Orient Europharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Orient management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Orient management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The data published in Orient Europharma's official financial statements usually reflect Orient Europharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Orient Europharma. For example, before you start analyzing numbers published by Orient accountants, it's critical to develop an understanding of what Orient Europharma's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Orient Europharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Orient Europharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Orient Europharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Orient Europharma Co. Please utilize our Beneish M Score to check the likelihood of Orient Europharma's management manipulating its earnings.
Orient Europharma Workforce Analysis
Traditionally, organizations such as Orient Europharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Orient Europharma within its industry.Orient Europharma Manpower Efficiency
Return on Orient Europharma Manpower
| Revenue Per Employee | 227M | |
| Revenue Per Executive | 227M | |
| Net Income Per Employee | 5.7M | |
| Net Income Per Executive | 5.7M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Orient Europharma Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Orient Stock analysis
When running Orient Europharma's price analysis, check to measure Orient Europharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Europharma is operating at the current time. Most of Orient Europharma's value examination focuses on studying past and present price action to predict the probability of Orient Europharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Europharma's price. Additionally, you may evaluate how the addition of Orient Europharma to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |